Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown SANOFI SNY

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.


Top institutional share ownership of Sanofi

Name Shares Shares % change Value Value % change
Dodge & Cox 75,650,666 -1.8% $2,876,238 -25.3%
DODGX - Dodge & Cox Stock Fund 53,417,728 -1.1% $2,030,942 -24.8%
Fmr Llc 18,203,971 -2.7% $692,114 -26.1%
Boston Partners 17,723,199 48.9% $677,539 13.9%
DODFX - Dodge & Cox International Stock Fund 16,913,192 1.0% $1,290,820 -23.7%
VGTSX - Vanguard Total International Stock Index Fund Investor Shares 14,308,691 1.8% $1,421,905 -4.3%
Fisher Asset Management, LLC 13,985,528 -20.6% $531,730 -39.7%
Price T Rowe Associates Inc /md/ 12,296,876 -28.7% $472,167 -45.3%
Bank Of America Corp /de/ 10,929,474 -19.2% $415,537 -38.6%
BlackRock Inc. 10,411,618 -19.8% $395,850 -39.0%

Top institutional buyers of Sanofi

Name Shares % change Value % change Shares Value
Jpmorgan Chase & Co 263.6% 176.3% 3,518,203 $133,762
Camber Capital Management LP 87.5% 42.5% 7,500,000 $285,150
Boston Partners 48.9% 13.9% 17,723,199 $677,539
JVLAX - John Hancock Disciplined Value Fund Class A 31.3% -0.2% 6,185,090 $235,157
Arrowstreet Capital, Limited Partnership 6.6% -19.0% 3,999,846 $152,074
Morgan Stanley 6.1% -19.4% 6,481,870 $246,440
Invesco Ltd. 3.5% -21.4% 5,581,308 $212,201
VTMGX - Vanguard Developed Markets Index Fund Admiral Shares 2.8% -22.4% 8,108,499 $617,434
FINVX - Fidelity Series International Value Fund 2.1% -4.0% 3,533,006 $351,087
VGTSX - Vanguard Total International Stock Index Fund Investor Shares 1.8% -4.3% 14,308,691 $1,421,905

Top institutional sellers of Sanofi

Name Shares % change Value % change Shares Value
TRVLX - T. Rowe Price Value Fund, Inc. -36.9% -52.0% 3,589,730 $136,482
Price T Rowe Associates Inc /md/ -28.7% -45.3% 12,296,876 $472,167
Fisher Asset Management, LLC -20.6% -39.7% 13,985,528 $531,730
BlackRock Inc. -19.8% -39.0% 10,411,618 $395,850
Bank Of America Corp /de/ -19.2% -38.6% 10,929,474 $415,537
BLACKROCK EQUITY DIVIDEND FUND - BLACKROCK EQUITY DIVIDEND FUND Investor A -15.7% -20.8% 3,857,464 $383,330
DODBX - Dodge & Cox Balanced Fund -5.5% -28.2% 5,288,865 $201,083
Fmr Llc -2.7% -26.1% 18,203,971 $692,114
Dodge & Cox -1.8% -25.3% 75,650,666 $2,876,238
IEFA - iShares Core MSCI EAFE ETF -1.4% -7.3% 5,934,876 $589,770

Information provided by Fintel.io